Final Conference Programme

Thursday 18th November 2010

SESSION 5:

ADJUVANTS
Moderator: Geert van den Bossche (Gates Foundation, Seattle, Washington, USA)

 

09.00-09.45
‘Crossover veterinary/human adjuvants and applications’
Kevin Harper (Sanofi Pasteur, Toronto, Canada)


09.45-10.15
‘DNA Vaccines and Lipid Adjuvants’
John Doukas (VICAL Inc., USA)


10.15-10.45
‘Adjuvant for live avian vaccines’
S. Deville, L. Dupuis, F. Bertrand and V. Borisov (SEPPIC, Paris, France)

 

10.45-11.15

Coffee Break & Posters


SESSION 6:

DELIVERY
Moderator: Virgil Schijns (Crossbeta Biosciences, Utrecht, The Netherlands)

 

11.15-12.00
‘Vaccine delivery platforms: Novel methods and designs’
Kevin Harper (Sanofi Pasteur, Toronto, Canada)

 

12.00-12.20
‘A novel vaccine delivery system for bovine tuberculosis utilising biodegradable polyester nanoparticles’
Natalie A. Parlane, Bernd H.A. Rehm, D. Neil Wedlock and Bryce M. Buddle
(AgResearch, Hopkirk Research Institute, Palmerston North, New Zealand)


12.20-12.40
‘Aminopeptidase N as a target for oral vaccine delivery’
Vesna Melkebeek, Katrien Vandamme, Chris Vervaet, Jean Paul Remon and Eric Cox(University of Ghent, Merelbeke, Ghent, Belgium)

 

12.40-14.00

Lunch Break & Posters

 

SESSION 7:

INFECTION & IMMUNE RESPONSE
Moderator: Cyril G. Gay (USDA, Maryland, USA)


14.00-14.30
‘Experimental infection studies in animals and humans to accelerate proof of concept’
Rob Lambkin-Williams (Retroscreen Virology Ltd, London, UK)


14.30-15.00
‘Assessing the quality of the immune response after vaccination in pigs and cattle’
Gregers Jungersen (Technical University of Denmark, Copenhagen, Denmark)


15.00-15.20
'The role of adjuvants in modulation of immune response of piglets induced by intradermal administration of antigen'
M. Toman, J. Krejei, K. Nechvatalova, J. Bernardy, H. Kudlackova, L. Leva, M. Faldyna
(Veterinary Research Institute, Brno, Czech Republic)

 

15.20-15.40

Tea Break & Posters


SESSION 8:

LATE BREAKING ABSTRACTS
Moderator: Alain Vanderplasschen (University of Liege, Belgium)


15.40-16.00
'Construction of a recombinant fowl adenovirus expressing the VP2 of infectious bursal diseases virus (IBDV)'
Eva Nagy, Yanlong Pei, Peter J. Krell and Thanh Hoa Le
(University of Guelph, Guelph, Ontario, Canada)


16.00-16.20
'Possibilities of overcoming the inhibitory effect of colostrum-derived antibodies using intradermal immunization and immunization via mucosae'
K. Nechvatalova, E. Gopfert, P. Turanek Knotigiova, H. Kudlackova, L. Leva and M. Faldyna
(Veterinary Research Institute, Brno, Czech Republic)


16.20-16.40
'The effects of propolis adjuvant to inactivated vaccine of porcine parvovirus on pigs'
Xia Ma, Zhenhuan Guo, Zhiqiang Shen and Hui Zhu
(Binzhou Animal Science & Veterinary Medicine Academy of Shandong Province, Binzhou, China)


16.40-17.00
'Immunization against Newcastle disease and bird flu H5N1 CDC strain using cinnamon fraction'
Michael Ovadia, Immanuel Kallily, Merav Kamensky and Avner Finger
(Tel Aviv University, Tel Aviv, Israel)

 

SESSION 9:

PANEL DISCUSSION


17.00-18.00
‘The One Health Concept: Pros, & Cons & Ethics’
Moderators:
Ray Spier (University of Surrey, Guildford, UK)
Peter Nara (Biological Mimetics Inc., Frederick, Maryland, USA)

Panel Discussion members – to be confirmed

 

Free Evening for Delegates